MFS
MACK

MSI Financial Services’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

MSI Financial Services’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4K Hold
135
– – ﹤0.01% 3299
2016
Q3 		$7K Sell
135
-127
-48% -$5.27K ﹤0.01% 3015
2016
Q2 		$11K Buy
262
+8
+3% +$436 ﹤0.01% 2750
2016
Q1 		$17K Hold
254
– – ﹤0.01% 2424
2015
Q4 		$16K Buy
254
+127
+100% +$8.94K ﹤0.01% 2461
2015
Q3 		$9K Hold
127
– – ﹤0.01% 2153
2015
Q2 		$12K Hold
127
– – ﹤0.01% 2054
2015
Q1 		$12K Hold
127
– – ﹤0.01% 2078
2014
Q4 		$11K Hold
127
– – ﹤0.01% 1797
2014
Q3 		$9K Hold
127
– – ﹤0.01% 1890
2014
Q2 		$7K Hold
127
– – ﹤0.01% 1972
2014
Q1 		$5K Hold
127
– – ﹤0.01% 2041
2013
Q4 		$5K Hold
127
– – ﹤0.01% 2009
2013
Q3 		$4K Hold
127
– – ﹤0.01% 1801
2013
Q2 		$7K Buy
+127
New +$5.57K ﹤0.01% 1713

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MSI Financial Services's MACK Position: Q4 2016 in Review

MSI Financial Services held its Merrimack Pharmaceuticals, Inc. (MACK) position steady in Q4 2016 at 135 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #3299.

MSI Financial Services first reported a position in MACK in Q2 2013 and has held it in 15 quarters since. The position peaked at $17K in Q1 2016. 136 funds tracked by Wall St. Rank hold MACK as of Q4 2016.

  • MSI Financial Services held 135 shares of Merrimack Pharmaceuticals, Inc. worth $4K as of Q4 2016.
  • MSI Financial Services left its Merrimack Pharmaceuticals, Inc. share count unchanged in Q4 2016.
  • Merrimack Pharmaceuticals, Inc. made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3299 holding.
  • MSI Financial Services first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
  • MSI Financial Services's Merrimack Pharmaceuticals, Inc. position peaked at $17K in Q1 2016.
  • 136 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.